Related references
Note: Only part of the references are listed.Safety, Immunogenicity, and Antibody Persistence following an Investigational Streptococcus pneumoniae and Haemophilus influenzae Triple-Protein Vaccine in a Phase 1 Randomized Controlled Study in Healthy Adults
Johan Berglund et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Role of Antibodies in Protection Elicited by Active Vaccination with Genetically Inactivated Alpha Hemolysin in a Mouse Model of Staphylococcus aureus Skin and Soft Tissue Infections
Christopher P. Mocca et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Protein Antigens Increase the Protective Efficacy of a Capsule-Based Vaccine against Staphylococcus aureus in a Rat Model of Osteomyelitis
Santiago M. Lattar et al.
INFECTION AND IMMUNITY (2014)
Prevention of Staphylococcus aureus Infections by Glycoprotein Vaccines Synthesized in Escherichia coli
Michael Wacker et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus
Timothy J. Foster et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial
Hans C. Rumke et al.
BMC INFECTIOUS DISEASES (2013)
Immunogenicity Analysis of Staphylococcus aureus Clumping Factor A Genetic Variants
Rebecca A. Brady et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
A Serologic Correlate of Protective Immunity Against Community-Onset Staphylococcus aureus Infection
Stephanie A. Fritz et al.
CLINICAL INFECTIOUS DISEASES (2013)
Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery A Randomized Trial
Vance G. Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults
Jaime Montoya et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Staphylococcus aureus Phenol-Soluble Modulin Peptides Modulate Dendritic Cell Functions and Increase In Vitro Priming of Regulatory T Cells
Jens Schreiner et al.
JOURNAL OF IMMUNOLOGY (2013)
Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age
Roman Chlibek et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
Janet E. McElhaney et al.
LANCET INFECTIOUS DISEASES (2013)
Long-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine An open-label, randomized study in adults aged 18-60 years and older
Pierre Van Damme et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
A Recombinant Clumping Factor A-Containing Vaccine Induces Functional Antibodies to Staphylococcus aureus That Are Not Observed after Natural Exposure
Julio Hawkins et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Progress Toward a Staphylococcus aureus Vaccine
Robert S. Daum et al.
CLINICAL INFECTIOUS DISEASES (2012)
Recurrent infections and immune evasion strategies of Staphylococcus aureus
Hwan Keun Kim et al.
CURRENT OPINION IN MICROBIOLOGY (2012)
Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)
Jamie D. Croxtall et al.
DRUGS (2012)
Lower Antibody Levels to Staphylococcus aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive S. aureus Infections
Rajan P. Adhikari et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Christina E. Zielinski et al.
NATURE (2012)
Novel Structurally Designed Vaccine for S. aureus α-Hemolysin: Protection against Bacteremia and Pneumonia
Rajan P. Adhikari et al.
PLOS ONE (2012)
Is there a future for a Staphylococcus aureus vaccine?
Richard A. Proctor
VACCINE (2012)
Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors
Annaliesa S. Anderson et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials
Fabio Bagnoli et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2012)
Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome
Yoshiyuki Minegishi et al.
YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY II (2011)
Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials
Francois Roman et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Human Monocytes Promote Th1 and Th17 Responses to Streptococcus pneumoniae
Marie Olliver et al.
INFECTION AND IMMUNITY (2011)
Staphylococcal Alpha-Toxin Is a Strong Inducer of Interleukin-17 in Humans
Margarete Niebuhr et al.
INFECTION AND IMMUNITY (2011)
H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
Philippe Moris et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Staphylococcus aureus Biofilms Prevent Macrophage Phagocytosis and Attenuate Inflammation In Vivo
Lance R. Thurlow et al.
JOURNAL OF IMMUNOLOGY (2011)
The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota
June L. Round et al.
SCIENCE (2011)
Comparative effects of carrier proteins on vaccine-induced immune response
Markus Knuf et al.
VACCINE (2011)
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
Sandra Morel et al.
VACCINE (2011)
Immunity against Staphylococcus aureus cutaneous infections
Lloyd S. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Evaluation of Clumping Factor A Binding Region A in a Subunit Vaccine against Staphylococcus aureus-Induced Mastitis in Mice
Rui Gong et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
A new view on development of a Staphylococcus aureus vaccine Insights from mice and men
Brad Spellberg et al.
HUMAN VACCINES (2010)
Role of Interleukin-17A in Cell-Mediated Protection against Staphylococcus aureus Infection in Mice Immunized with the Fibrinogen-Binding Domain of Clumping Factor A
Kouji Narita et al.
INFECTION AND IMMUNITY (2010)
Safety and Cross-Reactive Immunogenicity of Candidate AS03-Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults
Joanne M. Langley et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Targeting of Alpha-Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
Adam D. Kennedy et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Pneumolysin Activates the NLRP3 Inflammasome and Promotes Proinflammatory Cytokines Independently of TLR4
Edel A. McNeela et al.
PLOS PATHOGENS (2010)
Innate IL-17-producing cells: the sentinels of the immune system
Daniel J. Cua et al.
NATURE REVIEWS IMMUNOLOGY (2010)
10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix™
Roman Prymula et al.
EXPERT REVIEW OF VACCINES (2009)
Staphylococcal Vaccines and Immunotherapies
Adam C. Schaffer et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency
Yoshiyuki Minegishi et al.
INTERNATIONAL IMMUNOLOGY (2009)
CCR6 is required for IL-23-induced psoriasis-like inflammation in mice
Michael N. Hedrick et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome
Yoshiyuki Minegishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
Erin G. Harper et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Vaccination as infection control: A pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage
C. Buddy Creech et al.
VACCINE (2009)
Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice
Lin Lin et al.
PLOS PATHOGENS (2009)
The expression of alpha-haemolysin is required for Staphylococcus aureus phagosomal escape after internalization in CFT-1 cells
Todd M. Jarry et al.
CELLULAR MICROBIOLOGY (2008)
Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphylococcus aureus in Mice
Lorena P. N. Tuchscherr et al.
INFECTION AND IMMUNITY (2008)
Vaccine protection against Staphylococcus aureus pneumonia
Juliane Bubeck Wardenburg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells
Ludovic de Beaucoudrey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b
Pamela S. Hair et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A Potential New Pathway for Staphylococcus aureus Dissemination: The Silent Survival of S. aureus Phagocytosed by Human Monocyte-Derived Macrophages
Malgorzata Kubica et al.
PLOS ONE (2008)
Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
Isabel Leroux-Roels et al.
PLOS ONE (2008)
Fibrinogen Binding Sites P336 and Y338 of Clumping Factor A Are Crucial for Staphylococcus aureus Virulence
Elisabet Josefsson et al.
PLOS ONE (2008)
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
Pierre Vandepapeliere et al.
VACCINE (2008)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Hajo Grundmann et al.
LANCET (2006)
Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections
RA Proctor et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Confounding B-cell defences: lessons from a staphylococcal superantigen
GJ Silverman et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis
K Breuer et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A
A Loughman et al.
MOLECULAR MICROBIOLOGY (2005)
Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence
A Watts et al.
INFECTION AND IMMUNITY (2005)
Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus
B Postma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Development of StaphVAX™, a polysaccharide conjugate vaccine against S-aureus infection:: from the lab bench to phase III clinical trials
AI Fattom et al.
VACCINE (2004)
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers
HFL Wertheim et al.
LANCET (2004)
Staphylococcus aureus capsular polysaccharides
K O'Riordan et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Autoinduction and signal transduction in the regulation of staphylococcal virulence
RP Novick
MOLECULAR MICROBIOLOGY (2003)
Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults
JD Campbell et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Endogenous antimicrobial peptides and skin infections in atopic dermatitis
PY Ong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
H Shinefield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome
A Senthilkumar et al.
CLINICAL INFECTIOUS DISEASES (2001)
Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model
SH Cho et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers
P Richmond et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Toxic shock syndrome and bacterial superantigens: An update
JK McCormick et al.
ANNUAL REVIEW OF MICROBIOLOGY (2001)
Share Paper
